array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Tekla Life Sciences Investors"
["slug"]=>
string(38) "30be8-us-tekla-life-sciences-investors"
["logo"]=>
NULL
["description"]=>
string(523) "Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL."
["address_street"]=>
string(17) "2 Liberty Sq FL 9"
["address_place"]=>
string(6) "Boston"
["address_region"]=>
string(13) "Massachusetts"
["founding_date"]=>
string(10) "2000-01-26"
["website_domain"]=>
string(12) "teklacap.com"
["website_url"]=>
string(24) "https://www.teklacap.com"
["industry_codes"]=>
array(1) {
[0]=>
string(39) "Management Investment Offices, Open-End"
}
["employee_count"]=>
int(7)
["article_count"]=>
int(78)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(84) "Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P."
["snippet_en"]=>
string(296) "Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-11-30/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3002266e-8d28-47bf-a243-7dc9f574377a"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-11-30"
["categories"]=>
array(8) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(20) "Corporate Governance"
[2]=>
string(11) "Acquisition"
[3]=>
string(31) "Financial Update/Profit Warning"
[4]=>
string(16) "Share Repurchase"
[5]=>
string(14) "Issuing Shares"
[6]=>
string(12) "Stock Market"
[7]=>
string(18) "General Investment"
}
}
[1]=>
array(7) {
["title_en"]=>
string(72) "Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC"
["snippet_en"]=>
string(217) "RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)."
["url"]=>
string(112) "https://www.defenseworld.net/2023/10/09/johnson-johnson-nysejnj-shares-bought-by-rnc-capital-management-llc.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/541f0636-9fd8-491d-8e1a-8da06ab1b9dc"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-10-09"
["categories"]=>
array(9) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(11) "Acquisition"
[3]=>
string(16) "Share Repurchase"
[4]=>
string(18) "Expansion & Growth"
[5]=>
string(14) "Issuing Shares"
[6]=>
string(11) "Regulations"
[7]=>
string(12) "Stock Market"
[8]=>
string(18) "General Investment"
}
}
[2]=>
array(7) {
["title_en"]=>
string(82) "Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)"
["snippet_en"]=>
string(300) "Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-09-29/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/28564341-88d3-4b88-b2ed-9009ed96617e"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-09-29"
["categories"]=>
array(10) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(11) "Acquisition"
[3]=>
string(16) "Share Repurchase"
[4]=>
string(14) "Issuing Shares"
[5]=>
string(11) "Regulations"
[6]=>
string(19) "Investment Requests"
[7]=>
string(12) "Stock Market"
[8]=>
string(18) "General Investment"
[9]=>
string(24) "Stock Research & Ratings"
}
}
[3]=>
array(7) {
["title_en"]=>
string(90) "Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ..."
["snippet_en"]=>
string(160) "On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's stock."
["url"]=>
string(85) "https://finance.yahoo.com/news/insider-buying-president-daniel-omstead-090129980.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c4a0c45d-f201-4981-be22-137183d32e53"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-09-21"
["categories"]=>
array(4) {
[0]=>
string(11) "Acquisition"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(12) "Stock Market"
[3]=>
string(16) "Share Repurchase"
}
}
[4]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors (HQL) Declares $0.32 Dividend"
["snippet_en"]=>
string(205) "Tekla Life Sciences Investors said on August 15, 2023 that its board of directors declared a regular quarterly dividend of $0.32 per share ($1.28 annualized). Previously, the company paid $0.32 per share."
["url"]=>
string(91) "https://www.nasdaq.com/articles/tekla-life-sciences-investors-hql-declares-$0.32-dividend-0"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-08-24"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(35) "Tekla Life Sciences Investors (HQL)"
["snippet_en"]=>
string(185) "Get Tekla Life Sciences Investors historical price data for HQL stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change."
["url"]=>
string(80) "https://www.investing.com/equities/tekla-life-sciences-investors-historical-data"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2023-08-09"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(114) "Office Properties Income Trust, MFA Financial, Another 7 Companies Have A High Estimated Dividend Yield | Via News"
["snippet_en"]=>
string(299) "(VIANEWS) – Office Properties Income Trust (OPI), MFA Financial (MFA), TeklaLife Sciences Investors (HQL) have the highest dividend yield stocks on this list. A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price"
["url"]=>
string(119) "https://via.news/market/office-properties-income-trust-mfa-financial-another-7-companies-high-estimated-dividend-yield/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5956214f-4c16-4fa5-b6b3-6c00dcc444d9"
["source"]=>
string(8) "via.news"
["publication_date"]=>
string(10) "2023-02-25"
["categories"]=>
array(2) {
[0]=>
string(11) "Slush Funds"
[1]=>
string(12) "Stock Market"
}
}
[7]=>
array(7) {
["title_en"]=>
string(117) "WhiteHorse Finance, TeklaLife Sciences Investors, Another 6 Companies Have A High Estimated Dividend Yield | Via News"
["snippet_en"]=>
string(300) "(VIANEWS) – WhiteHorse Finance (WHF), TeklaLife Sciences Investors (HQL), Best Buy Co. (BBY) have the highest dividend yield stocks on this list. A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing"
["url"]=>
string(123) "https://via.news/markets/whitehorse-finance-teklalife-sciences-investors-another-6-companies-high-estimated-dividend-yield/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/df3805b5-b2b1-4028-9b1a-34d3c800733a"
["source"]=>
string(8) "via.news"
["publication_date"]=>
string(10) "2023-01-23"
["categories"]=>
array(4) {
[0]=>
string(21) "Competitive Behaviour"
[1]=>
string(21) "Shareholders Feedback"
[2]=>
string(11) "Slush Funds"
[3]=>
string(12) "Stock Market"
}
}
[8]=>
array(7) {
["title_en"]=>
string(35) "Tekla Life Sciences Investors (HQL)"
["snippet_en"]=>
string(102) "This page features all of the latest analysis and reports for the Tekla Life Sciences Investors stock."
["url"]=>
string(71) "https://au.investing.com/equities/tekla-life-sciences-investors-opinion"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2022-08-16"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Stock Research & Ratings"
}
}
}
["category_annotations"]=>
array(22) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(16)
}
[1]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[2]=>
array(2) {
["name"]=>
string(10) "Tax Havens"
["count"]=>
int(6)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(4)
}
[5]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(4)
}
[6]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(3)
}
[9]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(2)
}
[10]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(2)
}
[11]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(2)
}
[12]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(2)
}
[13]=>
array(2) {
["name"]=>
string(22) "Business Restructuring"
["count"]=>
int(2)
}
[14]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(1)
}
[16]=>
array(2) {
["name"]=>
string(23) "Supply Chain Management"
["count"]=>
int(1)
}
[17]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(1)
}
[18]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(1)
}
[19]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[20]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(1)
}
}
}
30be8-us-tekla-life-sciences-investors
Tekla Life Sciences Investors
Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
https://www.teklacap.com
Articles
78 Articles
Category
Management Investment Offices, Open-End
Description
Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL.
Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a
RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's stock.
Tekla Life Sciences Investors said on August 15, 2023 that its board of directors declared a regular quarterly dividend of $0.32 per share ($1.28 annualized). Previously, the company paid $0.32 per share.
Get Tekla Life Sciences Investors historical price data for HQL stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.
(VIANEWS) – Office Properties Income Trust (OPI), MFA Financial (MFA), TeklaLife Sciences Investors (HQL) have the highest dividend yield stocks on this list. A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price
(VIANEWS) – WhiteHorse Finance (WHF), TeklaLife Sciences Investors (HQL), Best Buy Co. (BBY) have the highest dividend yield stocks on this list. A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
